21 May 2009
Clotting disorder in the liver transplant recipients
D Porowski, M Sejdak, M Niemczyk, J Ziółkowski, A Chmura, L PączekAnn Transplant 2009; 14(1): 43-43 :: ID: 880354
Abstract
Background: The function of many organs depends on the time of achieving full liver efficiency after transplantation. The aim of the study was to estimate the influence of the transplanted liver's efficiency on selected coagulation parameters as well as the analysis of other factors infl uencing clotting disorder in the liver transplant recipients.
Material/Methods: Fifty-one patients after liver transplantation performed in 2002 were included into the study. The results of serum biochemistry, coagulation and blood cell count were retrospectively analysed at the time of liver transplantation and after 1, 2, and 5 years post-transplant. Also immunosuppressive regimen, presence of splenomegaly, and anticoagulation agents were taken into consideration.
Results: Improvement of transplanted liver function significantly influences the coagulation parameters in patients in the first year post-transplant. The statistically significant dependences were found between INR and albumin level (p=0.0000007), PT and ALT (p=0.00000006), and aPTT and ALT (p=0.00002). Factors not connected directly with transplanted liver efficiency (splenomegaly, immunosuppressive regimen and infections) are more important in the late period after transplantation.
Keywords: Liver Transplantation, clinical outcome
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






